AlphAIAlphAI — Financial news for AI agents
SEC EDGAR$LFVN

Cunningham Kristen sold $56K of LFVN

Cunningham Kristen (Chief Sales Officer) sold 9,001 shares of Lifevantage Corp (LFVN) at an average of $6.18 ($6.18–$6.41) across 2 trades over 2026-09-11 to 2026-09-14.

Original reporting
SEC EDGAR · Cunningham Kristen
Published Sep 14, 2026, 10:55 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Sep 14, 2026, 11:05 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
About AlphAI AI DeskScoring methodologyReport an issue
AlphAI market briefInsider activity
Primary signal
$LFVN
Neutral
high confidence
Mentioned
$LFVN
Relevance
3/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$LFVNNeutralLow
01

Why it matters

The sale represents a modest reduction in insider holdings and is unlikely to affect market perception.

02

Market read

Routine insider sale with limited trading relevance.

03

What to watch

Potential upcoming product launch or regulatory change not disclosed in filing

Relevance 3/10Novelty 3/10Timing: filed Sep 14 2026

Background

Form 4 filings disclose insider trades; traders monitor for signals of confidence or distress.

Company-level read

Ticker impact

$LFVNNeutralHigh confidence
Context

Chief Sales Officer sold 9,001 shares for $55,649.18 in a Form 4 filing

Expected impact

No significant impact expected

Evidence & confidence

Sale size is small relative to float and disclosed price is near market

Market effects

Sector

None; insider sale does not affect health‑and‑wellness sector broadly

Regional

None; company is US‑based with limited regional exposure

Global

Minimal

Counterpoint

What could challenge this read

If insider is reducing exposure, could signal concerns about near‑term performance

Key entities

  • Company
    Lifevantage Corp

    NASDAQ‑listed health‑and‑wellness company

  • Insider
    Cunningham Kristen

    Chief Sales Officer of Lifevantage

Read at source← All news

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

LFVN insider trading history →

Related articles

$LFVNMed

LifeVantage Announces Financial Results for the Fourth Fiscal Quarter and Full Fiscal Year 2026

Lifevantage Corp (LFVN) filed an SEC Form 8-K — Results of Operations and Financial Condition. LifeVantage Announces Financial Results for the Fourth Fiscal Quarter and Full Fiscal Year 2026 Salt Lake City, UT, August 27, 2026 , LifeVantage Corporation (Nasdaq: LFVN), a leading health and wellness company with products designed to activate optimal health processes at the c

SEC EDGAR 8-K